Our Companies 20mins. delay Media Careers Connect Altria | Our Companies | Philip Morris USA | Responsibility at PM USA | Supporting Cessation About Philip Morris USA Our Leadership Smoking & Health Issues Smokeless Tobacco & Health Issues Making Our Cigarettes Our Products & Ingredients Responsibility at PM USA Helping Reduce Underage Tobacco Use Preventing Underage Retail Access Supporting Positive Youth Development Select Historical Programs Supporting Cessation Marketing Practices Marketing Restrictions Smoking in Film Case Study Protecting Our Cigarette Brands Compliance & Integrity Research & Development Legislative Issues Tobacco Settlement Agreements Regulatory Reporting Supporting Cessation For adult consumers concerned about the health effects of smoking or smokeless tobacco use, the best thing to do is quit. We recognize that quitting can be difficult and many who try to quit do not succeed. If you're an adult tobacco user, we hope you'll choose one of our brands. However, if you decide to quit, we've developed a free resource to help you be more successful. We developed the QuitAssist® online resource in 2004 in conjunction with a review board with expertise in the area of smoking cessation. This website highlights the Centers for Disease Control and Prevention’s "Five Keys for Quitting." In 2011, we added information to support those trying to quit using other tobacco products. It helps connect adult tobacco users who have decided to quit to expert quitting information from public health authorities and others. Quit Assist® also provides information and resources in Spanish. We communicate about QuitAssist® through product websites, email and direct mail. In addition, we supported the Duke Center for Smoking Cessation for ten years. We contributed $37 million to this program that funded work through May 2014. Over the years, researchers at the Center have investigated and reported on new and better smoking cessation methods. For example, these researchers developed and validated a new nicotine patch dosing regimen that doubles abstinence rates. Share This Page Contact Us | Privacy | Terms of Use | Site Map © 1999 - Altria Group, Inc.